Advancing Liquid Biopsy Applications for RAS-Mutant Cancers to Optimize Targeted Therapy Strategies
Time: 1:30 pm
day: Conference Day 2
Details:
- How can liquid biopsy improve the detection and monitoring of RAS mutations to guide targeted therapy decisions?
- What challenges exist in standardizing ctDNA assays for RAS mutation detection across different tumor types and treatment settings?
- How can longitudinal liquid biopsy analysis help track treatment resistance and identify emerging RAS-driven escape mechanisms?
RAS-Mutant
